[Status report on allergen immunotherapy (hyposensitisation). Prepared by the WHO/IUIS Immunotherapy Subcommittee 1988].
作者信息
Malling H J
出版信息
Ugeskr Laeger. 1989 Nov 27;151(48):3249-52.
PMID:2595857
Abstract
摘要
相似文献
1
[Status report on allergen immunotherapy (hyposensitisation). Prepared by the WHO/IUIS Immunotherapy Subcommittee 1988].[变应原免疫疗法（减敏疗法）现状报告。由世界卫生组织/国际免疫学会联盟免疫疗法小组委员会于1988年编写]
Ugeskr Laeger. 1989 Nov 27;151(48):3249-52.
2
The current status of allergen immunotherapy (hyposensitisation). Report of a WHO/IUIS working group.
Allergy. 1989 Aug;44(6):369-79. doi: 10.1111/j.1398-9995.1989.tb04167.x.
3
Immunological mechanisms of allergen-specific immunotherapy.变应原特异性免疫疗法的免疫机制
Nat Rev Immunol. 2006 Oct;6(10):761-71. doi: 10.1038/nri1934.
4
Current status of allergen immunotherapy (hyposensitization). Report of a WHO/IUIS working Group.
Allerg Immunol (Leipz). 1989;35(4):235-47.
5
[WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].[世界卫生组织立场文件（摘要）——变应原免疫疗法：过敏性疾病的治疗性疫苗]
Wien Med Wochenschr. 1999;149(14-15):410-4.
6
[Specific immunotherapy: indications and contraindications].
Rev Med Suisse Romande. 1994 Mar;114(3):233-43.
7
Current status of allergen immunotherapy (hyposensitization): memorandum from a WHO/IUIS meeting.变应原免疫疗法（减敏疗法）的现状：世界卫生组织/国际免疫学会联合会会议纪要
Bull World Health Organ. 1989;67(3):263-72.
8
Allergen-specific immunotherapy: current concepts and future directions.变应原特异性免疫疗法：当前概念与未来方向。
Allergy. 2011 Jun;66(6):709-12. doi: 10.1111/j.1398-9995.2011.02595.x.
9
Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen.免疫疗法的口服途径：变应原的临床疗效和动力学
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 1997(91):56-64; discussion 64-7.
10
IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.IgE 介导的抗原呈递：在过敏中的作用及变应原免疫疗法的影响
Immunol Allergy Clin North Am. 2006 May;26(2):333-47, viii-ix. doi: 10.1016/j.iac.2006.02.004.
Zotero 插件